The full IPO calendar is available at IPOpremium. Scheduled IPOs are ranked by IPO size. Almost $5 billion in scheduled new offerings.
(1) Based in Detroit, MI, Ally Financial ($ALLY) scheduled a $2.5 billion IPO on the NYSE with a market capitalization of $12.8 billion at a price range midpoint of $26.50 for Thursday, April 10, 2014.
Founded in 1919, ALLY is a leading automotive financial services company with over 90 years of experience providing a broad array of financial products and services to automotive dealers and their customers.
(2) Based in Irving, TX, La Quinta Inns & Suites ($LQ) scheduled a $725 million IPO on the NYSE with a market capitalization of $2.4 billion at a price range midpoint of $19.50 for Wednesday, April 9, 2014.
LQ is a leading owner, operator and franchisor of select-service hotels primarily serving the midscale and upper-midscale segments under the La Quinta brand.
(3) Based in Oklahoma City, OK, Enable Midstream Partners, LP ($ENBL) scheduled a $500 million IPO on the NYSE with a market capitalization of $8.32 billion at a price range midpoint of $20 for Friday, April 11, 2014.
ENBL is a large-scale, growth-oriented limited partnership formed to own, operate and develop strategically located natural gas and crude oil infrastructure assets.
(4) Based in Teaneck, NJ, Phibro Animal Health ($PAHC) scheduled a $200 million IPO on the Nasdaq with a market capitalization of $662 million at a price range midpoint of $17 for Friday, April 11, 2014.
PAHC is a global diversified animal health and mineral nutrition company.
(5) Based in Athens, Greece, Stalwart Tankers (STST) scheduled a $150 million IPO on the NYSE with a market capitalization of $188 million at a price range midpoint of $12 for Thursday, April 10, 2014.
STST is Stalwart Tankers Inc., a company recently organized under the laws of the Republic of the Marshall Islands to own and operate a fleet of mid-size stainless steel chemical tankers.
(6) Based in Beijing, China, iKang Healthcare Group ($KANG) scheduled a $142 million IPO on the Nasdaq with a market capitalization of $839 million at a price range midpoint of $13 for Wednesday, April 9, 2014.
KANG is the largest provider in China’s fast growing private preventive healthcare services market, accounting for approximately 12.3% of market share in terms of revenue in 2013, according to Frost & Sullivan.
(7) Based in Oklahoma City, OK, Paycom Software ($PAYC) scheduled a $126 million IPO on the NYSE with a market capitalization of $956 million at a price range midpoint of $19 for Friday, April 11, 2014.
PAYC is a leading provider of a comprehensive, cloud-based human capital management (HCM) software solution delivered as SaaS.
(8) Based in Vancouver, Canada, City Office REIT ($CIO) scheduled a $101 million IPO on the NYSE with a market capitalization of $189 million at a price range midpoint of $15 for Friday, April 11, 2014.
CIO is a newly organized Maryland corporation formed on November 26, 2013 to acquire, own and operate high-quality office properties located within its specified markets in the United States.
(9) Based in Westminster, CO, Farmland Partners ($FPI) scheduled a $70 million IPO on the NYSE with a market capitalization of $102 million at a price range midpoint of $15 for Thursday, April 10, 2014.
FPI seeks to acquire high-quality primary row crop farmland located in agricultural markets throughout North America.
(10) Based in Plano, TX, Zoe’s Kitchen ($ZOES) scheduled a $70 million IPO on the NYSE with a market capitalization of $221 million at a price range midpoint of $12 for Friday, April 11, 2014.
ZOES is a specialty fast casual restaurant with Mediterranean-inspired dishes. As of February 24, 2014 ZOES had 111 restaurants in15 states.
(11) Based in Cambridge, MA, Cerulean Pharma ($CERU) scheduled a $60 million IPO on the Nasdaq with a market capitalization of $172 million at a price range midpoint of $12 for Thursday, April 10, 2014.
CERU’s nanopharmaceutical product candidates consist of proprietary polymers that are covalently linked to anti-cancer therapeutics, or payloads.
(12) Based in Emeryville, CA, Adamas Pharmaceuticals ($ADMS) scheduled a $51 million IPO on the Nasdaq with a market capitalization of $279 million at a price range midpoint of $17 for Thursday, April 10, 2014.
ADMS is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system, or CNS.
(13) Based in Burlington, MA, Aldeyra Therapeutics ($ALDX) scheduled a $25 million IPO on the Nasdaq with a market capitalization of $69 million at a price range midpoint of $11 for Friday, April 11, 2014.
ALDX is a biotechnology company focused primarily on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are thought to be related to a naturally occurring toxic chemical species known as free aldehydes.
Read Next
